HOLX logo

Hologic (HOLX) Company Overview

Profile

Full Name:

Hologic, Inc.

Sector:

Healthcare

Country:

United States

IPO:

March 1, 1990

Indexes:

Description:

Hologic, Inc. develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company conducts molecular diagnostic tests Aptima to detect infectious microorganisms; quantitative viral load tests Aptima for HIV, hepatitis C, and hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 tests for detecting SARS-CoV-2; ThinPrep system for cytology use; a rapid fetal fibronectin test to help doctors assess the risk of premature birth; diagnostic tests for detecting group B streptococcus. The company also offers breast imaging and analysis services. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 5, 2025

Recent annual earnings:

Nov 4, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 3, 2008

Analyst ratings

Recent major analysts updates

Mar 4, 25 Citigroup
Neutral
Feb 6, 25 Stephens & Co.
Overweight
Feb 6, 25 Raymond James
Outperform
Feb 6, 25 RBC Capital
Sector Perform
Feb 6, 25 Needham
Hold
Feb 6, 25 Leerink Partners
Market Perform
Feb 6, 25 Evercore ISI Group
In-Line
Feb 3, 25 Needham
Hold
Jan 13, 25 Needham
Buy
Jan 13, 25 Morgan Stanley
Equal-Weight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Hologic?
  • Does Hologic pay dividends?
  • What sector is Hologic in?
  • What industry is Hologic in?
  • What country is Hologic based in?
  • When did Hologic go public?
  • Is Hologic in the S&P 500?
  • Is Hologic in the NASDAQ 100?
  • Is Hologic in the Dow Jones?
  • When was Hologic's last earnings report?
  • When does Hologic report earnings?
  • Should I buy Hologic stock now?

What is the ticker symbol for Hologic?

The ticker symbol for Hologic is NASDAQ:HOLX

Does Hologic pay dividends?

No, Hologic does not pay dividends

What sector is Hologic in?

Hologic is in the Healthcare sector

What industry is Hologic in?

Hologic is in the Medical Instruments & Supplies industry

What country is Hologic based in?

Hologic is headquartered in United States

When did Hologic go public?

Hologic's initial public offering (IPO) was on March 1, 1990

Is Hologic in the S&P 500?

Yes, Hologic is included in the S&P 500 index

Is Hologic in the NASDAQ 100?

No, Hologic is not included in the NASDAQ 100 index

Is Hologic in the Dow Jones?

No, Hologic is not included in the Dow Jones index

When was Hologic's last earnings report?

Hologic's most recent earnings report was on Feb 5, 2025

When does Hologic report earnings?

The next expected earnings date for Hologic is May 2, 2025

Should I buy Hologic stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions